1-3 of 3
Jesper Jurlander, M.D.
Close
Sort by
Journal Articles

Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+ Diffuse Large B-Cell Lymphoma (DLBCL).

Akmal Safwat, M.D., Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Francesco d’Amore, MD
Journal: Blood
Blood (2008) 112 (11): 1013.
https://doi.org/10.1182/blood.V112.11.1013.1013
Published: 2008
Journal Articles

High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes

Rebeqa Gunnarsson, MSc, Anders Isaksson, PhD, Hanna Göransson, MSc, Larry Mansouri, PhD, Mattias Jansson, PhD, Nicola Cahill, MSc, Karin Ekström Smedby, M.D., PhD, Jesper Jurlander, M.D., PhD, Gunnar Juliusson, M.D., PhD, Richard Rosenquist, M.D., PhD
Journal: Blood
Blood (2008) 112 (11): 3133.
https://doi.org/10.1182/blood.V112.11.3133.3133
Published: 2008
Journal Articles

Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Akmal Safwat, MD, Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Anne Marie Boesen, M.D., Francesco d’Amore, M.D.
Journal: Blood
Blood (2007) 110 (11): 1296.
https://doi.org/10.1182/blood.V110.11.1296.1296
Published: 2007